Chugai Pharmaceutical Co. Ltd. - Other Cashflows From Financing Activities

Chugai Pharmaceutical Co. Ltd.'s Fiscal Year is From January To December - All Figures are in JPY, Billions.

The item "Other-Cashflows-From-Financing-Activities" stands at 594.10 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the highest value at least since 06/30/2012, the period currently displayed.

Chugai Pharmaceutical Co. Ltd.'s third quarter result of 409.42 Billion JPY for the item "Other Cashflows From Financing Activities" represents an increase of 39,166.51 percent compared to it's second quarter result.

Also, Chugai Pharmaceutical Co. Ltd.'s third quarter result of 409.42 Billion JPY for the item "Other Cashflows From Financing Activities" represents an increase of 208.26 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Chugai Pharmaceutical Co. Ltd.'s third quarter result of 594.10 Billion JPY for the item "Other Cashflows From Financing Activities" represents an increase of 87.12 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 335.51 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 335.51 Billion Japanese Yens.
The 3 year change is 595.39 Billion Japanese Yens.
The 5 year change is 593.33 Billion Japanese Yens.
The 10 year change is 537.84 Billion Japanese Yens.

The Serie's long term average value is 71.25 Billion Japanese Yens. It's latest available value, on 09/30/2025, is 522.85 Billion Japanese Yens higher, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 03/31/2022, to it's latest available value, on 09/30/2025, is +602.86 Billion.
The Serie's change in Japanese Yens from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0 Billion.